Last month, the company released new immunogenicity and safety data from the ongoing analysis of its proof-of-concept Phase I trial for the IMNN-101 DNA plasmid vaccine. "FDA aligns with Imunon ...
Ms Eagle said: “The Type 83 Destroyer will be the core of the Future Air Dominance System (FADS) programme, which has commenced its concept phase. FADS will replace the UK's present Maritime Air ...
In September 2023, each startup received $100,000 with the possibility of earning additional funding based on how they fared during the proof-of-concept phase through pilots conducted in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback